August 4, 2022
Capitol Forum
Stroock Partner Shannon Reaves and Associate Andrew Astuno provide insight into the in-depth reviews CFIUS has launched into previous proposed bioscience company acquisitions of US-based companies and if the Meridian deal could impact national security.
CFIUS “may likely engage in heightened scrutiny in a transaction involving a party with a less than-stellar compliance record,” said Andrew Astuno.
“During the review, the committee will assess whether the acquisition of Meridian could adversely affect the delivery of research and services it provides under government contracts,” Shannon Reaves states.
Read more in the full PDF here.
August 4, 2022
Capitol Forum
Stroock Partner Shannon Reaves and Associate Andrew Astuno provide insight into the in-depth reviews CFIUS has launched into previous proposed bioscience company acquisitions of US-based companies and if the Meridian deal could impact national security.
CFIUS “may likely engage in heightened scrutiny in a transaction involving a party with a less than-stellar compliance record,” said Andrew Astuno.
“During the review, the committee will assess whether the acquisition of Meridian could adversely affect the delivery of research and services it provides under government contracts,” Shannon Reaves states.
Read more in the full PDF here.
